Related references
Note: Only part of the references are listed.Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients
B. Szekely et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
Genetic Heterogeneity in Therapy-Naive Synchronous Primary Breast Cancers and Their Metastases
Charlotte K. Y. Ng et al.
CLINICAL CANCER RESEARCH (2017)
Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study
Janina Kulka et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)
Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study
Rumiko Tashima et al.
PLOS ONE (2015)
Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer
Claudette Falato et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study
Eduardo Martinez de Duenas et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
Gaetano Aurilio et al.
EUROPEAN JOURNAL OF CANCER (2014)
Discordance in Hormone Receptor Status Among Primary, Metastatic, and Second Primary Breast Cancers: Biological Difference or Misclassification?
Dominique Sighoko et al.
ONCOLOGIST (2014)
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis
M. V. Dieci et al.
ANNALS OF ONCOLOGY (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact
Toni Ibrahim et al.
ONCOLOGY (2013)
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
Eitan Amir et al.
CANCER TREATMENT REVIEWS (2012)
Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
Naoki Niikura et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Linda Sofie Lindstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
Eitan Amir et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Metastatic Breast Cancer, Version 1.2012 Featured Updates to the NCCN Guidelines
Robert W. Carlson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
To Biopsy or Not to Biopsy: Is That the Only Question?
Shaheenah Dawood et al.
ONCOLOGIST (2012)
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
Renata Duchnowska et al.
BREAST CANCER RESEARCH (2012)
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss
Giuseppe Bogina et al.
VIRCHOWS ARCHIV (2011)
Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
Reiki Nishimura et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
Lajos Pusztai et al.
ONCOLOGIST (2010)
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
Alastair M. Thompson et al.
BREAST CANCER RESEARCH (2010)
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
C. Simmons et al.
ANNALS OF ONCOLOGY (2009)
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
Robin L. Jones et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Impact of metastatic estrogen receptor and progesterone receptor status on survival
EE Lower et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Progesterone receptor status of breast cancer metastases
M Brankovic-Magic et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
